What are Edwards Lifesciences's profit margins?

Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.

Where do Edwards Lifesciences's ratios come from?

Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Edwards Lifesciences EW Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	312.9%-5.4pp	314.6%-3.8pp	316%-1.2pp	317.6%-2.2pp	318.3%-4.4pp
Operating margin	92.3%-12.8pp	96.7%-8.5pp	101.2%-5.9pp	103.5%-6.1pp	105.1%-6.6pp
Net margin	131.3%-128pp	189.6%-21.2pp	248.7%+86.6pp	303.6%+185pp	258.9%+136pp
EBITDA margin	102.7%-13.7pp	107.4%-9.3pp	112.2%-6.4pp	114.6%-7.2pp	116.5%-7.8pp
Returns
Return on equity	81.3%-90.0pp	119%-25.4pp	158.6%+41.8pp	196.1%+108pp	171.3%+82.4pp
Return on assets	61.9%-64.7pp	90.4%-14.9pp	119.6%+35.7pp	146.4%+83.8pp	126.6%+63.5pp
Return on invested capital	61%-15.8pp	65.1%-13.0pp	69.8%-10.6pp	73.9%-4.6pp	76.8%-0.4pp
Efficiency
Asset turnover	1.9×-0.1×	1.9×-0.2×	1.9×-0.2×	1.9×-0.2×	2×-0.1×
Inventory turnover	4.7×+0.5×	4.4×+0.3×	4.4×+0.1×	4.2×—	4.2×—
Liquidity
Current ratio	16.8×+1.0×	16.9×+1.8×	17.3×+3.0×	16.8×+2.6×	15.8×+2.2×
Quick ratio	13.9×+1.0×	13.9×+2.0×	14.3×+3.2×	13.9×+3.3×	12.9×+2.8×
Cash ratio	7.4×-0.2×	7.9×+1.5×	8.3×+3.0×	8.5×+4.0×	7.5×+3.4×
Leverage
Debt-to-equity	0.3×0.0×	0.3×-0.1×	0.3×-0.1×	0.3×-0.1×	0.3×-0.1×
Debt-to-assets	0.2×0.0×	0.2×0.0×	0.2×-0.1×	0.2×-0.1×	0.2×-0.1×
Net debt / EBITDA	-5.6×0.0×	-6×-1.6×	-5.9×-2.8×	-6.6×-4.8×	-5.6×-4.1×
Per Share
Book value per share	$70.79+13.8%	$70.24+23.8%	$69.28+35.9%	$67.81+47.7%	$62.18+41.1%
Valuation
Market capitalization	$185.79B+2.3%	$182.08B-7.4%	$176.27B-11.5%	$170.36B-15.5%	$181.53B-10.6%
Enterprise value	$177.23B+2.6%	$172.81B-8.9%	$166.88B-14.1%	$159.99B-19.5%	$172.78B-14.0%
Price / earnings	132.3×+64.3×	100.3×+1.9×	64.7×-56.3×	40.9×-100.0×	68×-76.3×
Price / sales	31.1×-2.8×	31.4×-6.0×	31.3×-7.3×	31×-10.2×	33.9×-10.1×
Price / book	17.9×-2.3×	17.7×-6.4×	17.3×-9.4×	16.9×-11.9×	20.2×-10.1×
EV / EBITDA	116.2×+5.7×	112.1×-11.7×	105.7×-21.4×	101.7×-32.4×	110.4×-29.8×
EV / sales	29.6×-2.6×	29.8×-6.3×	29.6×-8.1×	29.1×-11.6×	32.3×-11.3×
Earnings yield	16.9%-15.7pp	24.3%-0.8pp	31.7%+13.1pp	39.2%+27.7pp	32.5%+21.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Edwards Lifesciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Edwards Lifesciences's profit margins?: Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?: Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.